ArticlePDF Available

EFFECT OF VIBRATION AND HEAT COMBINATION ON PRIMARY DYSMENORRHEA

Authors:
  • Apple Chemie

Abstract and Figures

Background: Primary dysmenorrhoea is a common, idiopathic, chronic pelvic pain syndrome, with unknown aetiology which ‎about 50% of women with regular menstrual period suffer. This study was designed to determine the effect of vibration and heat on primary dysmenorrhea. Materials and Methods: In this clinical trial, 75 female students aged 18-22 years old were evaluated for two menstrual cycles. At the first cycle the participants received the routine pain-relief method (synthetic or herbal medicine and traditional remedies). At the second cycle for each participant combined vibration-heat device was applied for ten minutes during ‎menstrual pain. The average of perceived leg pain, lumbar pain and abdominal pain scores at two cycles were determined. The data were analyzed based on Wilcoxon and T tests by using SPSS (v 16.0) for Windows. Results: The average of all perceived pain scores at two cycles were significantly different before pain relief and after both routine methods and using the device (p<0.001). Those were more significantly reduced after using the device in comparison of using routine methods (p<0.001). Conclusion: Since “vibration-heat” is an effective pain relief method, it can be used as a complementary alternative medicine in primary dysmenorrhea reduction.
Content may be subject to copyright.
Bali Medical Journal (Bali Med J)
2015, Volume 4, Number 1: 12-16
P-ISSN.2089-1180, E-ISSN.2302-2914
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 12
EFFECT OF VIBRATION AND HEAT COMBINATION ON
PRIMARY DYSMENORRHEA
1Mansoureh Hoseini, 2Sheida Rafiezadeh Gharahtapeh, 3Azam Jahazi.
1Master science of Nursing, A Faculty Member of Islamic Azad University, Gorgan Branch,
Islamic Azad University, Gorgan Branch, Department of Nursing, Gorgan, Iran.
2Bachelor science of Nursing, A member of Young Researcher Club, Islamic Azad University,
Gorgan Branch, Gorgan, Iran.
3Master science of Midwifery, A faculty member of Islamic Azad University, Gorgan Branch,
Islamic Azad University, Gorgan Branch, Department of Midwifery, Gorgan, Iran.
Background: Primary dysmenorrhoea is a common, idiopathic, chronic pelvic pain syndrome, with
unknown aetiology which about 50% of women with regular menstrual period suffer. This study was
designed to determine the effect of vibration and heat on primary dysmenorrhea. Materials and
Methods: In this clinical trial, 75 female students aged 18-22 years old were evaluated for two
menstrual cycles. At the first cycle the participants received the routine pain-relief method (synthetic
or herbal medicine and traditional remedies). At the second cycle for each participant combined
vibration-heat device was applied for ten minutes during menstrual pain. The average of perceived
leg pain, lumbar pain and abdominal pain scores at two cycles were determined. The data were
analyzed based on Wilcoxon and T tests by using SPSS (v 16.0) for Windows. Results: The average
of all perceived pain scores at two cycles were significantly different before pain relief and after both
routine methods and using the device (p<0.001). Those were more significantly reduced after using
the device in comparison of using routine methods (p<0.001). Conclusion: Since ―vibration-heat‖ is
an effective pain relief method, it can be used as a complementary alternative medicine in primary
dysmenorrhea reduction.
Keywords: Vibration; Heat; Dysmenorrhea; vibration.
INTRODUCTION
Primary dysmenorrhoea is a common,
idiopathic, chronic pelvic pain syndrome, with
unknown aetiology.1 It is a frequently occurring
condition affecting a large proportion of young
women. The highest prevalence has been reported
in adolescent women, where as many as 5075%
suffer from dysmenorrhoea.2-7 Dysmenorrhea is
one of the major factors that decreases young
women's quality of life and social activities
specially if such symptoms as headache, fatigue,
nausea, vomiting, diarrhea, irritation, shivering and
muscle cramps are involved.8 About 15% of
Address of Correspondence:
Azam Jahazi
Master science of Midwifery, A faculty member of
Islamic Azad University, Gorgan Branch,
Department of Midwifery, Gorgan, Iran.
Email: ajahazi@gmail.com
adolescent and young women describe their
dysmenorrhoea as severe, causing regular
absenteeism from school and work.8-11 This
monthly disability, which interferes with daily
work several days each cycle, has been estimated to
account for 600 million lost working hours and two
billion dollars in lost productivity annually in the
USA.12 Effective management of dysmenorrhoea is
beneficial for both the afflicted individual and
society.
Systematic reviews and randomised
controlled trials have shown that non steroidal anti-
inflammatory drugs13-17 and hormonal regulation
through oral contraception18 are significantly more
effective for pain relief than placebo and are often
used for symptom control.19,20 However, some
women may not always find them effective or
acceptable. For example, owing to side effects in
the case of non-steroidal anti-inflammatory drugs.13
Non-drug treatments, including alternative and
physical Therapies such as topical heat, herbal
medicine, thiamine, vitamin E, fish oil, vegetarian
diet, low fat diet, acupuncture, acupressure and
Bali Medical Journal (Bali Med J)
2015, Volume 4, Number 1: 12-16
P-ISSN.2089-1180, E-ISSN.2302-2914
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 13
transcutaneous electrical nerve stimulation (TENS)
are increasingly being used for dysmenorrhoea.21
In different studies the effect of TENS on
primary dysmenorrhea,22 the effect of vibration on
chronic backache,23 and toothache were
identified.24 Vibration, moderate or fast
percussions and also deep pressure on painful
spots are pain relievers in dysmenorrhea.25 A
research on self-treatment patterns of young girls
for dysmenorrhea management showed that they
use heat to decrease their pain.26 Another research
study on the effect of physical activity on
dysmenorrhea showed that dysmenorrhea
prevalence in the athletic group was 3.2% less
than non-athletic group.27
The above mentioned problems of this
disorder and calls for its treatment prompted the
researcher and her colleagues to study the effect
of vibration and heat combination on
dysmenorrhea among the students of Islamic Azad
University, Gorgan Branch.
MATERIALS AND METHODS
Study design, setting and subjects: This is a
clinical trial conducted between Jun 2009 and
March 2010 in the girls’ dormitory of Islamic
Azad University of Gorgan (a city located in the
north of Iran). Seventy five 18-22 year-old girls
with a mediocre dysmenorrhea not having any
cardiovascular disease, severe anemia, chronic
headache, precedent pelvic surgery, secondary
dysmenorrhea and not being married were
studied. The sampling was purposeful and
voluntary.
Instruments
Demographic questionnaire, pain ruler and
vibration-heat device were used. Demographic
questionnaire consists of two-part: 1-demographic
characteristics (age, field of study, menarch age,
menstruation interval and the length of period)
and 2- clinical characteristic of dysmenorrhea (leg
pain, lumbar pain, abdominal pain). Vibration-
heat device vibrates with a frequency of 50 (Hz)
and heats up to 38 degrees in Celsius for ten
minutes. It is a portable, light weight (w=424gr)
and a safe device and is used as a belt on the
abdomen. Anti-dysmenorrhea 08 device with
registration no.58420 is from General Department
for Registration of Companies and Industrial
Ownership (General Department for Registration
of Documents and Landed Properties).
Data collection
During dysmenorrhea, participants were
asked to express their pain severity on a scale of
0-10 on the pain ruler, with 0 meaning no pain
and 10 meaning the most severe pain that an
individual might experience.
Each individual was studied for two
continuous menstrual periods. In both periods
participants filled out the checklists. On the first
period, no intervention was made by researchers
and participants were asked to fill out the
questionnaire according to the severity of pain
before and after using routine methods for relief
(synthetic medicine (Ibuprofen, Mefenamic Acid,
Hyoscine), herbals such as oxtongue boile,
solution of rock candy in hot water and
homemade treatments such as heating, massaging
and holding legs into belly). On the second period,
they were asked to use vibration-heat device for
ten minutes each time when the menstrual pain
began and they were told to use the device at a
maximum of three times for each pain. They were
told to avoid using other pain-relief methods as
long as possible but, if necessary, they could use
other methods. In the latter case they had to
mention the type, the quantity and the length of
that method.
Participants were referred to a gynecologist
for a pelvic ultrasonography to make sure that
there was not some pathologic factor in uterus and
ovaries (i.e. myoma, ovarian cyst).
The study was approved by the Islamic Azad
University, Gorgan branch, Medical Sciences
Research committee. The record number of study
in clinical trial site of IRAN is as IRCT:
201102195866N1. Written informed consent was
obtained from the participants before enrollment.
All ethics were observed in this study following
Helisinki Ethics.
Data analysis
Data were analyzed based on Wilcoxon and
T tests using SPSS (v 16.o) for Windows. The
confidence level was rated 95%.
RESULTS
Seventy five students were studied in two
cycles, 43% of whom were 20 years old, 82%
were Fars natives and 18% were Torkman natives.
All of participants were single. The subjects
mostly studied basic science, humanities and
medical science respectively. Menarche age of
42% of them was 13 years old. Minimum interval
between two periods was 21 days and maximum
interval was 40 days. Forty five percent of them
had a 28 day interval.
The shortest menstrual duration was 5 days
and the longest was 9 days and 53% of
participants had a 7 days menstrual duration.
The average of perceived pain score at two
cycles was significantly different before using
pain relief and after using both routine methods
and the device (P<0.001). It was more
significantly reduced after using the device in
Bali Medical Journal (Bali Med J)
2015, Volume 4, Number 1: 12-16
P-ISSN.2089-1180, E-ISSN.2302-2914
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 14
comparison of using routine methods (P<0.001).
Tables 1-3 show more details of the results.
While using the device, most of the
sample (53%) mentioned no side effect. A slight
redness of skin was reported in 8% of sample.
Table 1
Comparison of the average of pain severity
before and after routine methods
(control group)
Variable
Before pain
relief
After
routine
methods
Leg pain
4.52
3.45
Lumbar pain
5.25
4.08
Abdominal
pain
6.26
4.75
Total
5.34
4.09
p < 0.001 (Wilcoxon test)
Table 2
Comparison of the average of pain severity before
and after using the device (control group)
Variable
Before pain
relief
After using
device
Leg pain
2.93
4.52
Lumbar pain
3.34
5.25
Abdominal
pain
4.05
6.26
Total
3.44
5.34
p < 0.001 (Wilcoxon test)
Table 3
Comparison of the average of pain severity
between routine methods and using the device
Variable
After routine
methods
After using
device
Leg pain
2.93
3.45
Lumbar pain
3.34
4.08
Abdominal
pain
4.05
4.75
Total
3.44
4.09
p < 0.001 (T-test)
DISCUSSION
A study on the effects of TENS as a
treatment for primary dysmenorrhea among
students of Medical Science University of Tehran
showed that using TENS alone in the case group
had a remarkable decrease in pain in 65% of
participants in comparison with control group
(24%) and there was considerable decrease in
dysmenorrhea symptoms. Due to the results of
that study, TENS is a safe, effective and
nonopioid treatment of primary dysmenorrheal.19
Studying the effect of acupressure on Saninjiao
spot and Ibuprofen on primary dysmenorrhea on
students showed that the severity of the pain after
treatment in the first and second month hadn't a
significant difference, but the severity of pain
before and after treatment by acupressure and
Ibuprofen had a significant difference.28 In this
study the average severity of leg pain, lumbar pain
and abdominal pain during the first time before
using routine treatments and the device was 5.34,
while the average after using routine treatments
decreased to 4.09 and after using device to 3.44.
Studying the effect of physical activity on
dysmenorrhea comparing 250 students of Tarbiat
Mo'alem and 250 students of Physical Education
showed that dysmenorrhea prevalence was more
than 75% in each group. Dysmenorrhea
prevalence in the physical education group was
2.4% less than Tarbiat Mo'alem group. Prevalence
of dysmenorrhea in athletic group was 3.2% less
than non-athletic group. Prevalence and severity
of dysmenorrhea in athletic individuals
significantly decreased.27 Study on backache
reduction showed vibratory exercises in
comparison with tensive exercises had a
significant statistical relation to chronic backache
relief.20 Studying the effect of heat with
Acetaminophen showed when heat was used with
Acetaminophen, pain was decreased for a longer
time and topical heat would decrease
dysmenorrheal.29 Data gathered in this study
showed vibriation with heat had results similar to
physical exercise or other treatments such as using
synthetic medicine, herbal medicine and that
traditional remedies can be effective in decreasing
dysmenorrhea. Results of this study showed
vibration is a safe, non-invasive, non-drug way
and also during this research no considerable side
effects were observed or reported. Only a slight
side effect, that is, a moderate topical redness of
skin was observed in 8% of participants. In this
study, also, on the phase using routine methods
and on the second phase using the device, a
significant decrease was observed, therefore,
using the vibration-heat device was shown to be
more effective in pain relieving in comparison
with routine methods. A Study on the effect of
topical pressure and vibration on muscular pain
showed, when pressure is used with vibration, it
would decrease the pain by 11%. Vibration can
block the function of vast neurological fibers and
sciatic nerve and relieve the pain.30-32 The effect
of vibration on the pain reduction in the
mentioned study confirms vibratory effect of the
vibration device on pain reduction in our research.
CONCLUSION
Because this method is safe, it may be used
with common medicines or as an alternative
treatment for dysmenorrhea. Since this is the first
study on the relationship between vibration-heat
and dysmenorrhea, it is recommended in future
Bali Medical Journal (Bali Med J)
2015, Volume 4, Number 1: 12-16
P-ISSN.2089-1180, E-ISSN.2302-2914
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 15
studies should be done on different nationality
groups, other age classes and married individuals.
ACKNOWLEDGEMENT
We wish to thank the Research deputy of
Islamic Azad University, Gorgan Branch, Young
Researchers Club of Islamic Azad University,
Gorgan Branch, Students participating in this
study and all those who helped us. We would also
like to thank very much, Mr. shahin Hosseinian
MA in English, Mr. Reza Mokaram Ms in
Statistics and Dr. Zohre Montazeri, gynecologist .
References:
1. Khan KS, Champaneria R, Latthe PM. How
effective are non-drug, non-surgical treatments
for primary dysmenorrhoea? BMJ
2012;344:e3011 doi: 10.1136/bmj.e3011
2. Campell MA, McGrath PJ. Use of medication
by adolescents for the management of
menstrual discomfort. Arch Pediatr Adolesc
Med 1997;151:905913.
3. Andersch B, Milsom I. An epidemiologic study
of young women with dysmenorrhea. Am J
Obstet Gynecol 1982a;144:655660.
4. Robinson JC, Plichta S, Weisman CS,
Nathanson CA, Ensminger M. Dysmenorrhea
and the use of oral contraceptives in adolescent
women attending a family planning clinic. Am J
Obstet Gynecol 1992;166:578583.
5. Davis AR, Westhoff CL. Primary
Dysmenorrhea in Adolescent Girls and
Treatment with Oral Contraceptives. J Pedriatr
Adolesc Gynecol 2001;14:38.
6. Harlow SD, Campell OM. Epidemiology of
menstrual disorders in developing countries: a
systematic review. BJOG 2004;111:616.
7. Harlow SD, Park M. A longitudinal study of
risk factors for the occurrence, duration and
severity of menstrual cramps in a cohort of
college women. Br J Obstet Gynaecol
1996;103:11341142.
8. Burnett MA, Antao V, Black A, Feldman K,
Grenville A, Lea R, Lefebvre G, Pinsonneault
O, Robert M. Prevalence of primary
dysmenorrhea in Canada. J Obstet Gynaecol
Can 2005;27:765770.
9. Sundell G, Milsom I, Andersch B. Factors
influencing the prevalence and severity of
dysmenorrhea in young women. Br J Obstet
Gynaecol 1990; 97:588594.
10. Harlow SD, Ephross SA. Epidemiology of
menstruation and its relevance to women’s
health. Epidemiol Rev 1995;17:265286.
11. Dawood MY. Primary dysmenorrhea
advances in pathogenesis and management.
Obstet Gynecol 2006;108:428441.
12. Coco AS. Primary dysmenorrhea. Am Fam
Physician 1999;60: 489498.
13. Marjoribanks J, Proctor M, Farquhar C,
Sangkomkamhang US, Derks RS. Nonsteroidal
anti-inflammatory drugs for primary
dysmenorrhoea. Cochrane Database Syst Rev
2003;4: CD001751.
14. Nor Azlin MI, Maryasalwati I, Norzilawati
MN, Mahdy ZA, Jamil MA, Zainul Rashid MR.
The efficacy of etoricoxib vs mefenamic acid in
the treatment of primary dysmenorrhoea: a
randomised comparative trial. J Obstet
Gynaecol 2008;28:424-6.
15. Barbosa ICF. Comparative study of the efficacy
and safety of valdecoxib and piroxicam in the
treatment of patients with primary
dysmenorrhoea. Revista Brasileira de Medicina
2007;64:318-22.
16. Daniels S, Gitton X, Zhou W, Stricker K,
Barton S. Efficacy and tolerability of
lumiracoxib 200mg once daily for treatment of
primary dysmenorrhoea: results from two
randomized controlled trials. J Women Health
2008;17:423-37.
17. Daniels S, Robbins J, West CR, Nemeth MA.
Celecoxib in the treatment of primary
dysmenorrhoea: results from two randomized,
double-blind, active- and placebo-controlled,
crossover studies. Clin Ther 2009;31:1192-208.
18. Wong CL, Farquhar C, Roberts H, Proctor M.
Oral contraceptive pill for primary
dysmenorrhoea. Cochrane Database Syst Rev
2009;4:CD002120.
19. Daniels JP, Khan KS Chronic pelvic pain in
women. BMJ 2010;341:c4834.
20. Vercellini P, Vigano P, Somigliana E. The role
of the levonorgestrel-releasing intrauterine
device in the management of symptomatic
endometriosis. Curr Opin Obstet Gynecol
2005;17:359-65.
21. French L. Dysmenorrhea. American Family
Physician. 2005; 71(2): 292.
22. Robatjazi M. Influence of skin electrical nerve
stimulation on primary dysmenorrhea among
Tehran University of Medical Sciences [MSD
thesis].Tehran: TUMS;1997.
23. Rittweger J, Just K, Kautzsch K, Reeg P,
Felsenberg D. Treatment of chronic lower back
pain with lumbar extension and whole body
vibration exercise: a randomized controlled
trial. Spine 2002; 27(17):1892-34.
24. Hutchins HS, Young FA, Lackland DT,
Fishburn CP. The effectiveness of topical
anesthesia and vibration in alleviating the pain
of oral injections. Anesthesia Progress 1997
;44(3):87-9.
25. Pursell C. American Technology.
England:Wiley-Blackwell; 2001.
26. O'Connell K, Davis AR, Westhoff C. Self-
treatment patterns among adolescent girls with
Bali Medical Journal (Bali Med J)
2015, Volume 4, Number 1: 12-16
P-ISSN.2089-1180, E-ISSN.2302-2914
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 16
dysmenorrhea. J Pediatr Adolesc Gynecol 2006;
19(4):285-9.
27. Tirgartabri S. The physical activities on
dysmenorrea of 250 sport students and 250
teacher students [MSD thesis]. Kerman:
Kerman University of Medical Sciences; 1996.
28. Suhrabi Z, Tadayon M, Javadifar N.
Comparison of pressure effect on Sanyinjiao
point with that of Ibuprofen on primary
dysmenorrhea. J of IUMS 2006; 2(14): 30-
35.[In Persian, English abstract]
29. Akin M, Price W, Rodriguez GJr, Erasala G,
Hurley G, Smith RP. Continuous, low-level,
topical heat wrap therapy as compared to
acetaminophen for primary dysmenorrhea. J
Reprod Med 2004; 49(9):739-45.
30. Bakhtiary AH, Safavi-Farokhi Z, Aminian-far
A. Influence of vibration on delayed onset of
muscle soreness following eccentric exercise.
Br J Sports Med 2007;41:145-8.
31. Weerakkody NS, Percival P, Hickey MW,
Morgan DL, Gregory JE, Canny BJ, et al.
Effects of local pressure and vibration on
muscle pain from eccentric exercise and
hypertonic saline. Pain 2003;105(3):425-35.
32. Kakigi R, Shibasaki H. Mechanisms of pain
relief by vibration and movement. J Neurol
Neurosurg Psychiatry 1992; 55(4):282-6.
This work is licensed under
a Creative Commons Attribution
... Menurut Savitri (2015), di Indonesia angka kejadian Dismenore terdiri dari 54,89% Dismenore primer dan 9,36% Dismenore sekunder. Dismenorea primer adalah rasa nyeri kram pada perut bagian bawah saat menstruasi dengan etiologi yang tidak diketahui (Hoseini, 2015) yang dapat disebabkan oleh karena aktivitas prostaglandin. Dismenorea sekunder adalah kram perut saat menstruasi yang disebabkan karena adanya penyakit pada pelvis seperti fibrosis, adenomiosis, penyakit radang panggul, dan lain-lain (Madhubala, 2012). ...
Article
Full-text available
Masa remaja merupakan masa peralihan antara masa anak – anak menjadi dewasa, yang ditandai dengan pubertas. Pubertas pada wanita ditandai dengan menstruasi. Menstruasi merupakan proses alamiah, namun terkadang terdapat gangguan menstruasi yang sering mengganggu aktivitas, diantaranya adalah Dismenore. Dismenore dapat menyebabkan penurunan kualitas hidup remaja putri, maka harus ditangani agar tidak terjadi dampak yang lebih buruk. Dismenore berisiko terjadi pada wanita dengan kondisi malnutrisi dan status gizi lebih. Dismenore umumnya terjadi setelah menarche. Penelitian ini bertujuan untuk mengetahui hubungan status gizi dan menarche dengan Dismenore pada remaja di Kota Magelang. Penelitian ini merupakan penelitian observasional analitik dengan rancangan Cross sectional. Sampel dimasukkan dalam penelitian bila memenuhi kriteria, yaitu siswa SMA/SMK kelas X dan XI di Kota Magelang yang bersedia menjadi subyek penelitian dengan menandatangani informed consent. Teknik pengambilan sampel yaitu dengan purposive sampling untuk menentukan lokasi penelitian dan simple random sampling untuk menentukan responden penelitian. Pengumpulan data melalui wawancara dan pengukuran antropometri. Dari hasil penelitian didapatkan hasil bahwa terdapat hubungan status gizi dengan Dismenore dan terdapat hubungan menarche dengan Dismenore pada remaja di Kota Magelang.
Article
Full-text available
Background: Pain and stress of hemodialysis are experienced by more than 50% of patients who are suffering from renal disease; hence decreasing a part of these adverse effects can be effective on individual’s long term coping with hemodialysis. The current study was done to determine the effect of warm footbath with vibration on arteriovenous fistula puncture-related pain in hemodialysis patients. Methods: This clinical trial was conducted on 31 hemodialysis patients in 2014. The patients were selected by simple random sampling method and placed in one group. First, the pain intensity of all patients was measured in the six frequent hemodialysis sessions without any intervention (control method). After two weeks, the intervention of warm footbath with vibration was done on all patients and the pain intensity was measured for six frequent hemodialysis sessions (intervention method). The patients were received 40±2 °C footbath with vibration by foot massage spa machine for ten minutes; then, fistula needles were placed and the pain intensity was assessed by using a numerical rating scale. Data were analyzed by ANOVA and T test. Results: The study group had contained 20 males (64.5%), 11 females (35.5%), with an average age of 44.16±14.85 and a range of 18 to 65 years old, which shows that the pain intensity of the warm footbath with vibration method was lower than the control method (P< 0.05). Conclusions: Warm footbath with vibration can be used as an effective palliative method to reduce pain of hemodialysis patients.
Article
Full-text available
Primary dysmenorrhoea is a common, idiopathic, chronic pelvic pain syndrome, but its unknown aetiology prevents targeted treatment. Systematic reviews and randomised controlled trials have shown that non-steroidal anti-inflammatory drugs1 2 3 4 5 and hormonal regulation through oral contraception6 are significantly more effective for pain relief than placebo and are often used for symptom control.7 8 However, some women may not always find them effective or acceptable—for example, owing to side effects in the case of non-steroidal anti-inflammatory drugs.1 Non-drug treatments, including alternative and physical therapies, are increasingly being used for dysmenorrhoea. However, their effectiveness is still being debated. This paper is based on our review in Clinical Evidence in which we examined a number of systematic reviews and trials that looked at the effects of many treatments for primary dysmenorrhoea, identified through literature searches (from database inception until January 2010) of the Cochrane Library, Medline, Embase, and bibliographic databases of the US Food and Drug Administration and the UK Medicines and Healthcare Products Regulatory Agency.9 The quality of available evidence was moderate to poor, for both drug and non-drug treatments. In particular, well designed trials comparing interventions head to head or against placebo were scarce. The meta-analyses found that drug treatments (non-steroidal anti-inflammatory drugs and combined oral contraception) were effective. Evidence on surgical treatments found that laparoscopic uterine nerve ablation was ineffective.29 30 31 For non-drug treatments the review showed substantive uncertainty, which hampers the generation of clinical guidance. The table⇓ shows the results of our examination. View this table: Non-drug, non-surgical treatments for primary dysmenorrhoea ### Transcutaneous electrical nerve stimulation (TENS) A Cochrane review included seven very low quality randomised controlled trials (RCTs) of this physical treatment.10 Patients had greater pain relief with high frequency TENS than placebo (odds ratio 7.2, 95% confidence interval 3.1 to 16.5), but low …
Article
Full-text available
SUMMARY POINTS Chronic pelvic pain is a common and debilitating condition Women with chronic pelvic pain want to be taken seriously and attach a high value to identifying a cause for their pain No organic cause is found on laparoscopy in at least a third of women with chronic pelvic pain, and patients should be made aware of this before they consent to investigations Psychological symptoms, such as anxiety and depression, are frequently present Gynaecological treatment for chronic pelvic pain is often unsatisfactory even when directed by an identified cause A multidisciplinary approach is essential for effective management
Article
Introduction: Dysmenorrhea is described as a moderate or severe pain experienced during or immediately before menstruation and it can cause an alteration of women daily activities. Objective: To compare the efficacy and safety of valdecoxib, piroxicam, or placebo in the treatment of patients with primary dysmenorrhea. Methods: A total of 169 subjects were included in this multicenter, double blind, randomized study, to evaluate comparative of efficacy and safety of valdecoxib (Group 1) 40 mg bis a day (first day), and 40 mg once a day for two days in the first menstrual cycle and piroxicam 40 mg once a day for three days another cycle, versus piroxicam (Group 2) 40 mg once day for three days on the first menstrual cycle and valdecoxib 40 mg twice on the first day and once for two days another cycle. Both the groups were compared with placebo group, for two cycles. The efficacy was evaluated by pain relief calculated as the summed weighted pain relief scores to 8 hours (TOTPAR 8h). The SPID 8h, percent of subjects who took rescue medication and percent of subjects who took the second dose of study medication were used to mesure the secondary efficacy. Safety was assessed by adverse events reported by patients of the groups. Results and conclusions: The results of this study showed that valdecoxib is as effective as piroxicam to treat severe pain in women with primary dysmenorrhea. The safety profile of the two drugs was similar, and no serious adverse events was recorded during the study.
Article
Objective To describe how menstrual cramps vary from cycle to cycle within a woman over time. To examine the influence of weight and lifestyle factors on occurrence, duration, and severity of menstrual pain. Design A one-year prospective menstrual diary study. Participants One hundred and sixty-five women aged 17 to 19 years entering a local university in 1985. Main outcome measures The occurrence, length, and maximum severity of pain during a menstrual period. Results Menstrual pain occurred during 71.6% of observed menstrual bleeds, most commonly beginning the first day of menses. The median duration was two days. Sixty percent of women reported at least one episode of severe pain, while 13% reported severe pain more than half the time. Earlier age at menarche and long menstrual periods increased the occurrence, duration and severity of pain. In smokers, cramps tended to last longer. Being overweight was an important risk factor for menstrual cramps and doubled the odds of having a long pain episode. Frequent alcohol consumption decreased the probability of having menstrual cramps, but in women who had pain it increased duration and severity. Physical activity was not associated with any pain parameter. Conclusions Women who have pain lasting three days are an important target group for prophylactic therapy. The occurrence and severity of menstrual cramps is influenced by potentially modifiable characteristics including weight, smoking, and alcohol consumption. Doctors may wish to counsel women presenting with dysmenorrhoea about the importance of healthy lifestyles and about the inefficacy of alcohol consumption as a treatment for dysmenorrhoea.
Article
Background: Dysmenorrhoea (painful menstrual cramps) is common. Combined OCPs are recommended in the management of primary dysmenorrhoea. Objectives: To determine the effectiveness and safety of combined oral contraceptive pills for the management of primary dysmenorrhoea. Search strategy: We conducted electronic searches for randomised controlled trials (RCTs) in the Cochrane Menstrual Disorders and Subfertility Group Register of controlled trials CENTRAL, CCTR, MEDLINE, EMBASE, and CINAHL (first conducted in 2001, updated on 5 November 2008). Selection criteria: RCTs comparing all combined OCPs with other combined OCPs, placebo, no management, or management with nonsteroidal anti-inflammatories (NSAIDs) were considered. Data collection and analysis: Twenty three studies were identified and ten were included. Six compared the combined OCP with placebo and four compared different dosages of combined OCP. Main results: One study of low dose oestrogen and four studies of medium dose oestrogen combined OCPs compared with placebo, for a combined total of 497 women, reported pain improvement. For the outcome of pain relief across the different OCPs the pooled OR suggested benefit with OCPs compared to placebo (7 RCTs: Peto OR 2.01 [95% CI 1.32, 3.08]).The Chi-squared test for heterogeneity showed there is significant heterogeneity with an I(2) statistic of 64% and a significant chi-square test (14.06, df=5, p=0.02). A sensitivity analysis removing the studies with inadequate allocation concealment suggested significant benefit of treatment with the pooled OR of 2.99 (95% CI 1.76, 5.07) and heterogeneity no longer statistically significant and I(2) statistic of 0%.Three studies reported adverse effects (Davis 2005; Hendrix 2002; GPRG 1968) The adverse effects were nausea, headaches and weight gain. Two studies reported if women experienced any side effect and no evidence of an effect was found (3 RCTs: OR = 1.45 (95% 0.71, 2.94). There was no evidence of statistical heterogeneity.There were no studies identified that compared combined OCP versus non steroidal anti-inflammatory drugsThere was no evidence of a difference for the pooled studies for 3rd generation pro gestagens (OR = 1.11 (95% CI 0.79 - 1.57)). For the 2nd generation versus 3rd generation the OR was 0.44 (95% CI 0.23-0.84) suggesting benefit of the 3rd generation OCP but this was for a single study (Winkler 2003). Authors' conclusions: There is limited evidence for pain improvement with the use of the OCP (both low and medium dose oestrogen) in women with dysmenorrhoea. There is no evidence of a difference between different OCP preparations.
Article
Celecoxib, a cyclooxygenase-2 inhibitor, has established analgesic efficacy for the treatment of acute pain resulting from a variety of causes. This article describes 2 studies designed to assess the efficacy and tolerability of celecoxib in patients with primary dysmenorrhea. Two identical, 3-day, multiple-dose, randomized, double-blind, active- and placebo-controlled, crossover studies were carried out in women aged 18 to 44 years with primary dysmenorrhea (studies 1 and 2). The studies employed a 6-sequence, 3-period, complete-block crossover design over 3 menstrual cycles. Patients received celecoxib 400 mg, followed by celecoxib 200 mg no sooner than 12 hours after first dose (day 1), then celecoxib 200 mg q12h as necessary (days 2 and 3); naproxen sodium 550 mg followed by naproxen sodium 550 mg no sooner than 12 hours after first dose (day 1), then naproxen sodium 550 mg q12h as necessary (days 2 and 3); or placebo. Primary efficacy measures were time-weighted sum of total pain relief and time-weighted sum of pain intensity difference at 8 hours after administration of the first dose of study medication (TOTPAR[8] and SPID[8], respectively). Tolerability was assessed using routine physical examination, including vital sign measurements, and clinical laboratory analyses at screening and end of study. In total, 149 and 154 patients were randomized to 1 of the 6 treatment sequences in studies 1 and 2, respectively. Across treatment sequences, mean age ranges were 23.4 to 26.9 years (study 1) and 28.3 to 34.1 years (study 2). Mean weight ranges were 62.7 to 74.5 kg (study 1) and 69.2 to 86.7 kg (study 2). Most patients (96.6% in study 1, 80.5% in study 2) were white. Mean TOTPAR[8] values with celecoxib (study 1/study 2, 18.28/17.98) and naproxen sodium (20.59/21.27) were significantly greater than with placebo (12.82/12.98) (all, P < 0.001). Mean SPID[8] values were significantly greater with celecoxib (10.06/9.60) and naproxen sodium (11.48/11.71) than with placebo (5.96/6.41) (all, P < 0.001). Naproxen sodium was significantly different from celecoxib in TOTPAR[8] (study 2 only) and SPID[8] (both studies) (all, P < 0.001). In both studies, the adverse-events (AEs) profile was not significantly different between treatments, with the majority of AEs being related to primary dysmenorrhea and not medication. Less than 10% of patients experienced severe AEs in any treatment period. In these 2 identically designed studies in women aged 18 to 44 years, celecoxib 400 mg (followed by 200 mg q12h) was more effective, as measured using pain scores, in the treatment of primary dysmenorrhea compared with placebo. In each study, the primary efficacy measures-TOTPAR[8] and SPID[8] scores-were significantly improved with celecoxib and naproxen sodium compared with placebo. SPID[8] in both studies and TOTPAR[8] in study 2 were significantly improved with naproxen sodium compared with celecoxib. Both celecoxib and naproxen sodium were well tolerated and provided relief from menstrual pain within 1 hour of administration.
Article
This study examined the prevalance of dysmenorrhea in female adolescents and the effect of experiencing a reduction in dysmenorrhea on oral contraceptive use. This was a prospective panel study in which 308 adolescent women at an inner-city family planning clinic were interviewed about their experiences with dysmenorrhea and their oral contraceptive use at three points in time over a 6-month period. A chi 2 test and multiple logistic regression analysis were done. The overall prevalence of dysmenorrhea in this population was 79.6%; 18.2% reported severe dysmenorrhea. Those who had severe dysmenorrhea and also experienced the reduction of dysmenorrhea as a result of oral contraceptives were eight times more likely to be consistent oral contraceptive users (p less than or equal to 0.02). It is important to screen female adolescents for dysmenorrhea, provide them with information about the beneficial side effects of oral contraceptives, and follow up these young women to make sure they are experiencing the alleviation of their symptoms.
Article
Mechanisms of pain relief induced by vibration and movement were investigated. A CO2 laser beam, which is useful for pure nociceptive stimulation, was used for recording pain-related somatosensory evoked potentials (pain SEPs) and for measuring pain threshold and reaction time (RT). Concurrently applied vibratory stimuli to and active movements of the fingers significantly reduced and prolonged pain SEPs, increased pain threshold, and prolonged RT, indicating that an increase in the inhibitory mechanisms of painful feeling was induced by the concurrently adopted sensory inputs mediated by large myelinated fibres. In contrast, continuous cooling enhanced pain SEPs and decreased pain threshold, probably due to the spatial summation of two kinds of nociceptive impulses mediated by the same pathways. The results of this investigation throw light on the mechanisms of the alleviation of pain by vibration and movement.
Article
Factors influencing the prevalence and severity of dysmenorrhoea were assessed longitudinally in a representative sample of young women born in 1962. The prevalence of dysmenorrhoea was lower (P less than 0.01) at 24 years of age than at 19 years of age. At 24 years of age, 67% of the women still experienced dysmenorrhoea; 10% reported dysmenorrhoea which limited daily activity. The severity of dysmenorrhoea (linear analogue scale) was lower (P less than 0.001) at 24 years of age (3.4, SD 2.8) than at 19 years (4.1, SD 3.2). The prevalence and severity of dysmenorrhoea were reduced (P less than 0.05) in women who were parous in 1986 and nulliparous in 1981, but was unchanged in women who were still nulliparous or women who had had a miscarriage or abortion. Dysmenorrhoea was reduced (P less than 0.001) in oral contraceptive users. The severity of dysmenorrhoea was significantly associated with the duration of menstrual flow, menarcheal age and cigarette smoking. The severity of dysmenorrhoea was not associated with age as an isolated factor, nor with height, weight, length of menstrual cycle or frequency of physical exercise.